Related Experiment Video
Updated: Jun 17, 2026
11:13
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
Published on: September 14, 2013
[Clostridium difficile associated diarrhea (CDAD)--hard to crack].
1Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital.
Harefuah
|December 24, 2009
Summary
Clostridium difficile-associated diarrhea (CDAD) is a growing hospital concern, especially with the emergence of the virulent NAP1/BI/027 strain. This article reviews current challenges and updated solutions for diagnosing, treating, and preventing CDAD.
Area of Science:
- Infectious Diseases
- Gastroenterology
- Hospital Epidemiology
Background:
- Clostridium difficile-associated diarrhea (CDAD) is the leading cause of hospital-acquired diarrhea globally.
- Significant increases in CDAD morbidity and mortality have been observed, linked to the emergence of the hypervirulent NAP1/BI/027 strain.
- Despite advances, complex challenges persist in the clinical management of CDAD.
Purpose of the Study:
- To discuss the persistent diagnostic, therapeutic, and preventive challenges posed by Clostridium difficile-associated diarrhea.
- To review updated strategies and potential solutions for managing CDAD, particularly in light of emerging strains.
- To provide a comprehensive overview of the current landscape of CDAD management.
Main Methods:
- Literature review of recent studies on Clostridium difficile-associated diarrhea.
- Analysis of epidemiological data concerning CDAD trends and the NAP1/BI/027 strain.
- Synthesis of information on diagnostic advancements, therapeutic options, and prevention strategies.
Main Results:
- The NAP1/BI/027 strain has been associated with increased severity and outbreaks of CDAD worldwide.
- Ongoing difficulties in accurate diagnosis, effective treatment, and robust prevention methods remain.
- Substantial research efforts are underway to develop improved diagnostic tools, novel therapeutics, and enhanced control measures.
Conclusions:
- Clostridium difficile-associated diarrhea presents ongoing clinical and public health challenges.
- Continued development of diagnostic accuracy, therapeutic efficacy, and preventive strategies is crucial.
- Addressing the complexities of CDAD management requires a multi-faceted approach, incorporating new research findings and clinical best practices.
Related Concept Videos
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:12Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...